复发性-话题@MedSci

#复发性#

452篇内容 | 2916人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909960, encodeId=b11f1909960f9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=BMJ：女性复发性尿路感染预防性抗生素的替代治疗, objectType=article, longId=300630, objectId=7c1b300630ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c1b300630ec, replyNumber=0, likeNumber=101, createdTime=2022-05-05, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c1b300630ec, moduleTitle=BMJ：女性复发性尿路感染预防性抗生素的替代治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c1b300630ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909955, encodeId=e93b190995515, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Annals of Neurology：脊髓萎缩，可预测复发性多发性硬化的进展, objectType=article, longId=295498, objectId=1e4a29549807, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4a29549807, replyNumber=0, likeNumber=74, createdTime=2022-05-20, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4a29549807, moduleTitle=Annals of Neurology：脊髓萎缩，可预测复发性多发性硬化的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4a29549807)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909979, encodeId=d5b419099e991, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Hepatology: 肝移植后出现复发性自身免疫性肝炎的危险因素和结局分析, objectType=article, longId=730063, objectId=037ee30063ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=037ee30063ff, replyNumber=0, likeNumber=80, createdTime=2022-07-27, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=037ee30063ff, moduleTitle=J Hepatology: 肝移植后出现复发性自身免疫性肝炎的危险因素和结局分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=037ee30063ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909962, encodeId=2d45190996201, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择, objectType=article, longId=300992, objectId=cea030099207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea030099207, replyNumber=0, likeNumber=100, createdTime=2022-06-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea030099207, moduleTitle=Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cea030099207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909973, encodeId=643e19099e3c4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响, objectType=article, longId=727501, objectId=ccafe275011b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccafe275011b, replyNumber=0, likeNumber=75, createdTime=2022-11-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccafe275011b, moduleTitle=HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccafe275011b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909983, encodeId=4ee719099834c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=BMJ：不孕、复发性流产以及反复死产女性需警惕中风风险, objectType=article, longId=730792, objectId=c363e30792f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c363e30792f1, replyNumber=0, likeNumber=112, createdTime=2023-02-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c363e30792f1, moduleTitle=BMJ：不孕、复发性流产以及反复死产女性需警惕中风风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c363e30792f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909986, encodeId=77161909986ec, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：Lisocabtagene maraleucel二线治疗难治性/复发性大B细胞淋巴瘤, objectType=article, longId=732664, objectId=82c1e326649a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82c1e326649a, replyNumber=0, likeNumber=126, createdTime=2023-03-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c1e326649a, moduleTitle=Lancet Oncol：Lisocabtagene maraleucel二线治疗难治性/复发性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c1e326649a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909947, encodeId=55b9190994e25, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性髌骨脱位的评估与诊断, objectType=article, longId=294738, objectId=744f294e38e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744f294e38e1, replyNumber=0, likeNumber=100, createdTime=2022-09-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744f294e38e1, moduleTitle=复发性髌骨脱位的评估与诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744f294e38e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909958, encodeId=7ed6190995814, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin Cancer Res：地西他滨联合PARP抑制剂他唑帕尼治疗难治性/复发性急性髓性白血病, objectType=article, longId=299624, objectId=273529962455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=273529962455, replyNumber=0, likeNumber=119, createdTime=2022-06-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=273529962455, moduleTitle=Clin Cancer Res：地西他滨联合PARP抑制剂他唑帕尼治疗难治性/复发性急性髓性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=273529962455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909943, encodeId=b8e0190994389, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Haematologica：Isatuximab 加卡非佐米和地塞米松与卡非佐米和地塞米松在肾功能不全的复发性多发性骨髓瘤患者中的比较, objectType=article, longId=292200, objectId=8c42292200d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c42292200d9, replyNumber=0, likeNumber=115, createdTime=2022-06-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c42292200d9, moduleTitle=Haematologica：Isatuximab 加卡非佐米和地塞米松与卡非佐米和地塞米松在肾功能不全的复发性多发性骨髓瘤患者中的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c42292200d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909941, encodeId=a0bd190994160, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, objectType=article, longId=292166, objectId=891e29216606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891e29216606, replyNumber=0, likeNumber=82, createdTime=2022-03-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891e29216606, moduleTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891e29216606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909966, encodeId=f0d5190996654, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价, objectType=article, longId=301455, objectId=e01c301455ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01c301455ef, replyNumber=0, likeNumber=93, createdTime=2022-06-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01c301455ef, moduleTitle=JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01c301455ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909991, encodeId=76f21909991e7, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Rheumatology：复发性或难治性SLE缓解诱导后的利妥昔单抗维持治疗, objectType=article, longId=736513, objectId=a3e7e36513f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3e7e36513f0, replyNumber=0, likeNumber=110, createdTime=2023-05-27, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3e7e36513f0, moduleTitle=Rheumatology：复发性或难治性SLE缓解诱导后的利妥昔单抗维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3e7e36513f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909965, encodeId=69f4190996592, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Thorac Cancer：卡铂+白蛋白-紫杉醇联合治疗复发性小细胞肺癌（SCLC）的疗效, objectType=article, longId=301524, objectId=dfda301524c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfda301524c5, replyNumber=0, likeNumber=87, createdTime=2023-01-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfda301524c5, moduleTitle=Thorac Cancer：卡铂+白蛋白-紫杉醇联合治疗复发性小细胞肺癌（SCLC）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfda301524c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909957, encodeId=40e6190995e1f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, objectType=article, longId=295669, objectId=d4cf2956690e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4cf2956690e, replyNumber=0, likeNumber=69, createdTime=2023-01-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4cf2956690e, moduleTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4cf2956690e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909949, encodeId=605319099490f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌, objectType=article, longId=295065, objectId=466a295065dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=466a295065dc, replyNumber=0, likeNumber=101, createdTime=2022-02-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=466a295065dc, moduleTitle=Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=466a295065dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909976, encodeId=6e7119099e621, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, objectType=article, longId=728258, objectId=3b8ae28258e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b8ae28258e7, replyNumber=0, likeNumber=102, createdTime=2023-05-05, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b8ae28258e7, moduleTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b8ae28258e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909938, encodeId=baaf19099388b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后, objectType=article, longId=221456, objectId=362222145662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362222145662, replyNumber=0, likeNumber=73, createdTime=2022-09-15, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362222145662, moduleTitle=NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=362222145662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909937, encodeId=2cfe190993e1f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=ESMO Open：紫杉醇联合卡铂的一线方案加用贝伐珠单抗治疗复发性/转移性鼻咽癌, objectType=article, longId=221315, objectId=ce4a22131527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce4a22131527, replyNumber=0, likeNumber=96, createdTime=2022-07-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce4a22131527, moduleTitle=ESMO Open：紫杉醇联合卡铂的一线方案加用贝伐珠单抗治疗复发性/转移性鼻咽癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce4a22131527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909970, encodeId=1adc19099e048, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin Cancer Res：FGFR抑制剂Infigratinib单药治疗携带EGFR变异的复发性胶质瘤的疗效, objectType=article, longId=723401, objectId=df51e23401fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df51e23401fa, replyNumber=0, likeNumber=89, createdTime=2022-11-28, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df51e23401fa, moduleTitle=Clin Cancer Res：FGFR抑制剂Infigratinib单药治疗携带EGFR变异的复发性胶质瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df51e23401fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

BMJ：女性复发性尿路感染预防性抗生素的替代治疗

2022-05-05

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Annals of Neurology：脊髓萎缩，可预测复发性多发性硬化的进展

2022-05-20

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Hepatology: 肝移植后出现复发性自身免疫性肝炎的危险因素和结局分析

2022-07-27

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择

2022-06-18

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响

2022-11-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

BMJ：不孕、复发性流产以及反复死产女性需警惕中风风险

2023-02-18

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：Lisocabtagene maraleucel二线治疗难治性/复发性大B细胞淋巴瘤

2023-03-18

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性髌骨脱位的评估与诊断

2022-09-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin Cancer Res：地西他滨联合PARP抑制剂他唑帕尼治疗难治性/复发性急性髓性白血病

2022-06-13

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Haematologica：Isatuximab 加卡非佐米和地塞米松与卡非佐米和地塞米松在肾功能不全的复发性多发性骨髓瘤患者中的比较

2022-06-14

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性

2022-03-25

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价

2022-06-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Rheumatology：复发性或难治性SLE缓解诱导后的利妥昔单抗维持治疗

2023-05-27

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Thorac Cancer：卡铂+白蛋白-紫杉醇联合治疗复发性小细胞肺癌（SCLC）的疗效

2023-01-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌

2023-01-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌

2022-02-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究

2023-05-05

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后

2022-09-15

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

ESMO Open：紫杉醇联合卡铂的一线方案加用贝伐珠单抗治疗复发性/转移性鼻咽癌

2022-07-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin Cancer Res：FGFR抑制剂Infigratinib单药治疗携带EGFR变异的复发性胶质瘤的疗效

2022-11-28

科室
- - 订阅+
  - 更多科室
工具
服务